Panion & Bf Biotech Inc. (1760.TW)
TWD 66.3
(3.11%)
TWD 66.3
(3.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 538.09 Million TWD | -1.38% |
| 2022 | 545.64 Million TWD | 3.24% |
| 2021 | 528.52 Million TWD | -5.73% |
| 2020 | 560.65 Million TWD | 56.43% |
| 2019 | 358.41 Million TWD | 10.06% |
| 2018 | 325.64 Million TWD | 57.91% |
| 2017 | 206.21 Million TWD | 14.55% |
| 2016 | 180.01 Million TWD | -19.49% |
| 2015 | 223.59 Million TWD | 12.88% |
| 2014 | 198.08 Million TWD | 25.03% |
| 2013 | 158.43 Million TWD | -18.6% |
| 2012 | 194.63 Million TWD | -8.93% |
| 2011 | 213.7 Million TWD | 15.52% |
| 2010 | 184.99 Million TWD | 28.64% |
| 2009 | 143.8 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 532.75 Million TWD | -1.0% |
| 2024 Q1 | 538.12 Million TWD | 0.01% |
| 2023 FY | 538.09 Million TWD | -1.38% |
| 2023 Q4 | 538.09 Million TWD | -8.7% |
| 2023 Q1 | 589.49 Million TWD | 8.04% |
| 2023 Q3 | 589.35 Million TWD | 3.6% |
| 2023 Q2 | 568.88 Million TWD | -3.5% |
| 2022 Q2 | 557.87 Million TWD | 2.9% |
| 2022 Q4 | 545.64 Million TWD | 2.24% |
| 2022 Q1 | 542.16 Million TWD | 2.58% |
| 2022 FY | 545.64 Million TWD | 3.24% |
| 2022 Q3 | 533.67 Million TWD | -4.34% |
| 2021 Q2 | 580.86 Million TWD | -1.37% |
| 2021 Q3 | 571.13 Million TWD | -1.68% |
| 2021 Q4 | 528.52 Million TWD | -7.46% |
| 2021 FY | 528.52 Million TWD | -5.73% |
| 2021 Q1 | 588.92 Million TWD | 5.04% |
| 2020 Q3 | 437.71 Million TWD | 9.41% |
| 2020 Q2 | 400.07 Million TWD | 9.09% |
| 2020 Q1 | 366.74 Million TWD | 2.32% |
| 2020 Q4 | 560.65 Million TWD | 28.09% |
| 2020 FY | 560.65 Million TWD | 56.43% |
| 2019 Q2 | 330.36 Million TWD | -4.61% |
| 2019 FY | 358.41 Million TWD | 10.06% |
| 2019 Q3 | 344.55 Million TWD | 4.3% |
| 2019 Q4 | 358.41 Million TWD | 4.02% |
| 2019 Q1 | 346.31 Million TWD | 6.35% |
| 2018 Q3 | 291.16 Million TWD | 23.62% |
| 2018 FY | 325.64 Million TWD | 57.91% |
| 2018 Q4 | 325.64 Million TWD | 11.84% |
| 2018 Q2 | 235.53 Million TWD | 17.94% |
| 2018 Q1 | 199.71 Million TWD | -3.15% |
| 2017 Q4 | 206.21 Million TWD | -7.45% |
| 2017 FY | 206.21 Million TWD | 14.55% |
| 2017 Q3 | 222.81 Million TWD | 6.51% |
| 2017 Q2 | 209.2 Million TWD | 0.0% |
| 2017 Q1 | - TWD | -100.0% |
| 2016 Q1 | 187.01 Million TWD | -16.36% |
| 2016 Q2 | 187.01 Million TWD | 0.0% |
| 2016 Q4 | 180.01 Million TWD | 0.0% |
| 2016 FY | 180.01 Million TWD | -19.49% |
| 2015 Q1 | 205.03 Million TWD | 3.51% |
| 2015 FY | 223.59 Million TWD | 12.88% |
| 2015 Q2 | 205.03 Million TWD | 0.0% |
| 2015 Q4 | 223.59 Million TWD | 0.0% |
| 2015 Q3 | 223.59 Million TWD | 9.05% |
| 2014 Q1 | 192.47 Million TWD | 21.49% |
| 2014 Q2 | 192.47 Million TWD | 0.0% |
| 2014 FY | 198.08 Million TWD | 25.03% |
| 2014 Q4 | 198.08 Million TWD | 0.0% |
| 2014 Q3 | 198.08 Million TWD | 2.92% |
| 2013 Q1 | 198.64 Million TWD | 2.06% |
| 2013 Q2 | 198.64 Million TWD | 0.0% |
| 2013 Q3 | 158.43 Million TWD | -20.24% |
| 2013 Q4 | 158.43 Million TWD | 0.0% |
| 2013 FY | 158.43 Million TWD | -18.6% |
| 2012 Q2 | 233.17 Million TWD | 0.0% |
| 2012 Q3 | 194.63 Million TWD | -16.53% |
| 2012 FY | 194.63 Million TWD | -8.93% |
| 2012 Q4 | 194.63 Million TWD | 0.0% |
| 2011 Q2 | 215.12 Million TWD | 0.0% |
| 2011 FY | 213.7 Million TWD | 15.52% |
| 2011 Q4 | 213.7 Million TWD | 0.0% |
| 2010 Q4 | 184.99 Million TWD | 0.0% |
| 2010 FY | 184.99 Million TWD | 28.64% |
| 2009 FY | 143.8 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Apex Biotechnology Corp. | 747.71 Million TWD | 28.034% |
| Sinphar Pharmaceutical Co.,Ltd. | 839.19 Million TWD | 35.879% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 1.21 Billion TWD | 55.567% |
| GenMont Biotech Incorporation | 88.11 Million TWD | -510.656% |
| Abnova (Taiwan) Corporation | 408.3 Million TWD | -31.789% |
| Adimmune Corporation | 526.4 Million TWD | -2.221% |
| Tanvex BioPharma, Inc. | 108.28 Million TWD | -396.928% |
| Polaris Group | 36.35 Million TWD | -1380.121% |
| Energenesis Biomedical CO.,LTD. | 733 Thousand TWD | -73310.368% |
| UnicoCell Biomed Co., Ltd. | 5.45 Million TWD | -9771.547% |
| PELL Bio-Med Technology Co. Ltd. | 3.76 Million TWD | -14199.708% |